Similar Papers

Paper Title
Journal
Date
Author
Abstract 1372: BTN1A1 regulates T cell-mediated cancer immunotherapy by interacting with Galectin-9, PD-1, and TIM3
Seung Hoon Lee ... Andrew H Park
Cancer Research | VOL. 84
Seung Hoon Lee, et. al.Seung Hoon Lee ... Andrew H Park
22 Mar 2024
Honokiol-mediated Inhibition of PI3K/mTOR Pathway
Courtney Crane ... Jack Arbiser
Journal of Immunotherapy | VOL. 32
Courtney Crane, et. al.Courtney Crane ... Jack Arbiser
01 Jul 2009
Sarcoma Common MHC-I Haplotype Restricts Tumor-Specific CD8+ T Cell Response.
Laura Mosca ... Filomena De Nigris
Cancers | VOL. 14
Laura Mosca, et. al.Laura Mosca ... Filomena De Nigris
14 Jul 2022
Molecular imaging of cell-mediated cancer immunotherapy
Giovanni Lucignani ... Mario Clerici
Trends in Biotechnology | VOL. 24
Giovanni Lucignani, et. al.Giovanni Lucignani ... Mario Clerici
25 Jul 2006
View more papers

More From: Biomaterials

Paper Title
Journal
Date
Author
BRD4-targeted photodegradation nanoplatform for light activatable melanoma therapy.
Shiman Lu ... Lin Mei
Biomaterials | VOL. 317
Shiman Lu, et. al.Shiman Lu ... Lin Mei
10 Jan 2025
A 177Lu-nucleotide coordination polymer-incorporated thermosensitive hydrogel with anti-inflammatory and chondroprotective capabilities for osteoarthritis treatment.
Peng Liu ... Shuo Hu
Biomaterials | VOL. 317
Peng Liu, et. al.Peng Liu ... Shuo Hu
09 Jan 2025
Ultrasound-triggered drug-loaded nanobubbles for enhanced T cell recruitment in cancer chemoimmunotherapy.
Deng Liu ... Yanli Guo
Biomaterials | VOL. 317
Deng Liu, et. al.Deng Liu ... Yanli Guo
02 Jan 2025
Corrigendum to "Antioxidative and antibacterial gallium (III)-phenolic coating for enhanced osseointegration of titanium implants via pro-osteogenesis and inhibiting osteoclastogenesis" [Biomaterials 301 (2023) 122268
Kui Xu ... Qiqing Zhang
Biomaterials | VOL. -
Kui Xu, et. al.Kui Xu ... Qiqing Zhang
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.